US Patent Issued to OPHIREX on March 3 for "Early management, mitigation and prevention of sepsis and sepsis-like syndromes, including neo-natal ARDS due to infection, injury or iatrogenesis" (California, Florida Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,575, issued on March 3, was assigned to OPHIREX INC (Corte Madera, Calif.).

"Early management, mitigation and prevention of sepsis and sepsis-like syndromes, including neo-natal ARDS due to infection, injury or iatrogenesis" was invented by Matthew R. Lewin (Corte Madera, Calif.) and Rebecca Carter (Shalimar, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the early treatment, including pre-diagnosis treatment, of sepsis and acute inflammatory syndromes such as systemic inflammatory response syndrome (SIRS) by PLA2 and metalloprotease inhibitors to improve the performance of antibiotics and outcomes prior to and ...